Rotherham biotechnology company, Kirkstall Ltd, has secured an export deal which is expected to result in its advanced cell culture system being used by researchers around the world.
Based in Templeborough, the firm is pioneering the Quasi Vivo System that provides “in-vivo” like conditions for cell growth.
The system consists of interconnected cell-culture chambers and a pump to create a continuous flow of media over cells. As a result, cultures are exposed to conditions that are much more like those found in the human body, increasing the predictive value of experiments.
Kirkstall recently signed a worldwide marketing and distribution agreement with a leading Swiss life-science company, Lonza – a group which had sales of £2.6 billion in 2017.
Read the full story at Rothbiz.